You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanoma in-transit metastases (ITMs)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolic and Immune Dysfunction in In-transit Melanoma

Recruiting
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 11, 2022

Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)

Recruiting
  • Melanoma Stage III
  • In-Transit Metastasis of Cutaneous Melanoma
  • Encorafenib + Binimetinib
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Mar 2, 2023

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Anti-PD-L1 Monoclonal Antibody IMC-001
  • Punch Biopsy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

Not yet recruiting
  • Melanoma (Skin)
  • BMS-986213 (Relatlimab-Nivolumab FDC)
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

Not yet recruiting
  • Malignant Melanoma
  • Liver Metastases
  • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
  • (no location specified)
Dec 23, 2022

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Magnetic Resonance Imaging using 7 Tesla MRI
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

Not yet recruiting
  • Metastatic Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Oct 14, 2022

Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

Recruiting
  • Metastatic Melanoma
  • Metastasis to Brain
  • Tampa, Florida
  • +1 more
Jan 30, 2023

Melanoma Metastatic in the Brain Trial in Gainesville (CA-4948, Pembrolizumab)

Not yet recruiting
  • Melanoma Metastatic in the Brain
  • Gainesville, Florida
    University of Florida
Dec 20, 2022

Melanoma, Brain Metastases Trial in Spain (Ipilimumab)

Completed
Has Results
  • Melanoma
  • Brain Metastases
  • Badalona, Spain
  • +11 more
Oct 10, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

Recruiting
  • Brain Metastases
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Bevacizumab Injection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Uveal Melanoma Trial in Spain (Tislelizumab, Sitravatinib Malate)

Not yet recruiting
  • Uveal Melanoma
  • Málaga, Andalucia, Spain
  • +5 more
Sep 13, 2022

Uveal Melanoma, Liver Metastases Trial in Gothenburg (Isolated hepatic perfusion, Ipilimumab, Nivolumab)

Recruiting
  • Uveal Melanoma
  • Liver Metastases
  • Isolated hepatic perfusion
  • +2 more
  • Gothenburg, Sweden
    Sahlgrenska University Hospital
May 3, 2022

Malignant Melanoma Trial in Herlev, Aarhus, Odense (Pembrolizumab Injection [Keytruda], Ipilimumab Injection [Yervoy], Nivolumab

Recruiting
  • Malignant Melanoma
  • Pembrolizumab Injection [Keytruda]
  • +6 more
  • Herlev, Hovedstaden, Denmark
  • +2 more
Sep 16, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +6 more
  • Ipilimumab
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 12, 2022

Melanoma, Renal Cell Carcinoma, Brain Metastases Trial in New Haven (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma
  • +6 more
  • New Haven, Connecticut
    Yale University
Feb 18, 2022

Melanoma Trial in Ottawa, Toronto, Montreal (Vemurafenib, Cobimetinib)

Active, not recruiting
  • Melanoma
  • Ottawa, Ontario, Canada
  • +2 more
Oct 25, 2022

Malignant Melanoma Trial in Milan (Pembrolizumab)

Recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • Milan, Italy
    IEO Istituto Europeo di Oncologia
May 12, 2022

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022